ENO1 and breast carcinoma: In a study of breast cancer, a xenograft model was established by injecting breast cancer cells with small interfering RNA (siRNA) ENO1 into nude mice; reduced angiogenesis in the tumor tissue was observed with declined tumor growth and diminished tumor volume and weight.